Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs


This recording was made using enhanced software.

Summary

Quid pro quo

Texas Attorney General Ken Paxton sued Eli Lilly, the drug maker that produces Mounjaro, accusing it of bribing doctors to prescribe its products.

Free nurses

The company is accused of providing nurses and other support services to doctors in exchange for writing prescriptions.

Eli Lilly's response

The company said multiple courts and the federal government have rejected claims against Lilly as meritless


Full story

Texas Attorney General Ken Paxton filed a lawsuit against Eli Lilly, accusing the drug maker of bribing doctors to prescribe their medications. Paxton said the quid pro quo arrangements tainted millions of dollars of claims to Texas Medicaid. 

The lawsuit accuses Eli Lilly of providing doctors offices with free nurses to conduct patient-care services. That work is largely unprofitable and time-consuming; the nurses allow doctors to see more patients and write more prescriptions. The suit also states that Eli Lilly provides support services, such as ensuring a patient’s insurance covers the drug, so doctors and their staff don’t have the added tasks, which are also not billable.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

“Big Pharma compromised medical decision-making by engaging in an illegal kickback scheme,” Paxton said in a statement. “Eli Lilly fraudulently sought to maximize profits at taxpayer expense and put corporate greed over people’s health.” 

The drugs covered under the alleged kick-pack scheme include: 

  • Basaglar (diabetes) 
  • Ebglyss (eczema) 
  • Mounjaro (type 2 diabetes and weight loss
  • Zepbound (obesity and obstructive sleep apnea) 

The company is accused of violating the Texas Anti-Kickback Statute, which makes it illegal to directly or indirectly pay a bribe, in cash or in kind, to recommend the purchase of a product. 

Eli Lilly said the US government determined in a prior case that the Texas AG’s allegations lack sufficient factual and legal support. The company added that the federal government determined, “federal healthcare programs have a strong interest in ensuring that, after a physician has appropriately prescribed a medication, patients have access to basic product support relating to their medication.”  

“Multiple courts and the federal government have rejected claims by this same corporate relator against Lilly as meritless,” an Eli Lilly spokesperson told SAN. “We intend to vigorously defend against these allegations.”  

Paxton previously sued Eli Lilly, Express Scripts, CVS Pharmacy and others, alleging a conspiracy to inflate insulin prices.

Tags: , , , , ,

SAN provides
Unbiased. Straight Facts.

Don't just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Why this story matters

The lawsuit filed by Texas Attorney General Ken Paxton against Eli Lilly highlights concerns over potential illegal kickbacks in the pharmaceutical industry and questions about the integrity of physician prescribing practices and Medicaid spending.

Pharmaceutical kickbacks

Allegations that Eli Lilly provided free services to doctors raise questions about compliance with anti-kickback laws and the influence of drug companies on prescribing behavior.

Healthcare costs and Medicaid

The claims involve potential misuse of taxpayer funds and the integrity of Medicaid claims, impacting public trust and health care spending oversight.

Legal and regulatory challenges

The case underscores ongoing disputes between government officials and pharmaceutical companies over what constitutes acceptable industry support versus illegal inducements.

SAN provides
Unbiased. Straight Facts.

Don't just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Media landscape

Click on bars to see headlines

18 total sources

Key points from the Left

No summary available because of a lack of coverage.

Report an issue with this summary

Key points from the Right

No summary available because of a lack of coverage.

Report an issue with this summary

Powered by Ground News™